{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:08:54Z","timestamp":1791277734593,"version":"4.1.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"DOI":"10.2146\/ajhp130165","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T15:06:09Z","timestamp":1387379169000},"page":"37-43","source":"Crossref","is-referenced-by-count":55,"title":["Risk of hepatotoxicity associated with fluoroquinolones: A national case\u2013control safety study"],"prefix":"10.1093","volume":"71","author":[{"given":"Thamir M.","family":"Alshammari","sequence":"first","affiliation":[{"name":"College of Pharmacy, Hail University, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Paul","family":"Larrat","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Rhode Island (URI), Kingston; at the time of this study, he was Professor of Pharmacy, College of Pharmacy, URI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley J.","family":"Morrill","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Program, Providence Veterans Affairs Medical Center (VAMC), Providence, RI, and College of Pharmacy, URI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling R.","family":"Caffrey","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Program, Providence VAMC, and Assistant Professor of Pharmacoepidemiology, College of Pharmacy, URI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Quilliam","sequence":"additional","affiliation":[{"name":"College of Pharmacy, URI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry L.","family":"Laplante","sequence":"additional","affiliation":[{"name":"College of Pharmacy, URI; Providence VAMC; and Adjunct Clinical Associate Professor of Medicine, Brown University, Providence"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041210494697800_b1-0710037","first-page":"82","article-title":"Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting","volume":"28","author":"LaPlante","year":"2008"},{"key":"2019041210494697800_b2-0710037","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00646-06","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration\u2013time curve\/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin","volume":"51","author":"LaPlante","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"2019041210494697800_b3-0710037","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1086\/428055","article-title":"Antimicrobial safety: focus on fluoroquinolones","volume":"41","author":"Owens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2019041210494697800_b4-0710037","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkr159","article-title":"Hepatic safety of antibiotics used in primary care","volume":"66","author":"Andrade","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2019041210494697800_b5-0710037","unstructured":"Food and Drug Administration. Trovan information. www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHealthcareProfessionals\/PublicHealthAdvisories\/ucm052276.htm (accessed 2012 Sep 9)."},{"key":"2019041210494697800_b6-0710037","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1345\/aph.1G111","article-title":"Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection","volume":"39","author":"Coban","year":"2005","journal-title":"Ann Pharmacother"},{"key":"2019041210494697800_b7-0710037","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00428-003-0917-9","article-title":"Ciprofloxacin-induced acute liver injury: case report and review of literature","volume":"444","author":"Zimpfer","year":"2004","journal-title":"Virchows Arch"},{"key":"2019041210494697800_b8-0710037","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.4076\/1757-1626-2-8063","article-title":"Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report","volume":"2","author":"Verma","year":"2009","journal-title":"Cases J"},{"key":"2019041210494697800_b9-0710037","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2011.02.019","article-title":"Clinical and histopathologic features of fluoroquinolone-induced liver injury","volume":"9","author":"Orman","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019041210494697800_b10-0710037","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00228-011-1201-6","article-title":"Fluoroquinolone-induced liver injury: three new cases and a review of the literature","volume":"68","author":"Licata","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"2019041210494697800_b11-0710037","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0168-8278(95)80045-X","article-title":"Cholestatic hepatitis related to quinolones: a report of two cases","volume":"23","author":"Hautekeete","year":"1995","journal-title":"J Hepatol"},{"key":"2019041210494697800_b12-0710037","first-page":"847","article-title":"Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient","volume":"168","author":"Schwalm","year":"2003"},{"key":"2019041210494697800_b13-0710037","first-page":"434","article-title":"Severe ciprofloxacin-induced acute hepatitis","volume":"20","author":"Contreras","year":"2001"},{"key":"2019041210494697800_b14-0710037","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/j.1572-0241.2002.05873.x","article-title":"Moxifloxacin-induced acute liver injury","volume":"97","author":"Soto","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2019041210494697800_b15-0710037","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/106002809202600504","article-title":"Fulminant hepatic failure possibly related to ciprofloxacin","volume":"26","author":"Grassmick","year":"1992","journal-title":"Ann Pharmacother"},{"key":"2019041210494697800_b16-0710037","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(94)91624-1","article-title":"Fatal hepatic failure associated with ciprofloxacin","volume":"343","author":"Fuchs","year":"1994","journal-title":"Lancet"},{"key":"2019041210494697800_b17-0710037","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-8278(01)00082-4","article-title":"Acute fatal hepatitis related to levofloxacin","volume":"35","author":"Spahr","year":"2001","journal-title":"J Hepatol"},{"key":"2019041210494697800_b18-0710037","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1503\/cmaj.111823","article-title":"Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study","volume":"184","author":"Paterson","year":"2012","journal-title":"CMAJ"},{"key":"2019041210494697800_b19-0710037","unstructured":"National Center for Veterans Analysis and Statistics, Department of Veterans Affairs. Quick facts. www.va.gov\/vetdata\/ (accessed 2013 Jun 2)."},{"key":"2019041210494697800_b20-0710037","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s15010-011-0232-3","article-title":"Changing epidemiology of methicillin-resistant Staphylococcus aureus in the Veterans Affairs Healthcare System, 2002\u20132009","volume":"40","author":"Caffrey","year":"2012","journal-title":"Infection"},{"key":"2019041210494697800_b21-0710037","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/AAC.00200-10","article-title":"Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus","volume":"54","author":"Caffrey","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2019041210494697800_b22-0710037","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2710.2007.00853.x","article-title":"Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study","volume":"32","author":"Heaton","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"2019041210494697800_b23-0710037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.327.7405.18","article-title":"Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs","volume":"327","author":"Traversa","year":"2003","journal-title":"BMJ"},{"key":"2019041210494697800_b24-0710037","author":"Hosmer","year":"2000","edition":"2nd ed"},{"key":"2019041210494697800_b25-0710037","first-page":"946","article-title":"Temafloxacin syndrome: review of 95 cases","volume":"18","author":"Blum","year":"1994"},{"key":"2019041210494697800_b26-0710037","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1021\/tx7003085","article-title":"In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity","volume":"21","author":"Sun","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"2019041210494697800_b27-0710037","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJM200002033420517","article-title":"Acute eosinophilic hepatitis from trovafloxacin","volume":"342","author":"Chen","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041210494697800_b28-0710037","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2007.03572.x","article-title":"The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases","volume":"27","author":"Kramer","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"2019041210494697800_b29-0710037","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1185\/030079907X188099","article-title":"The safety profile of moxifloxacin and other fluoroquinolones in special patient populations","volume":"23","author":"Iannini","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"2019041210494697800_b30-0710037","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00002018-200932050-00001","article-title":"Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes","volume":"32","author":"Van Bambeke","year":"2009","journal-title":"Drug Saf"},{"key":"2019041210494697800_b31-0710037","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"De Valle","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2019041210494697800_b32-0710037","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure","volume":"376","author":"Bernal","year":"2010","journal-title":"Lancet"},{"key":"2019041210494697800_b33-0710037","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","article-title":"Risk factors for idiosyncratic drug-induced liver injury","volume":"138","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"key":"2019041210494697800_b34-0710037","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.37.3.379","article-title":"Valproic acid hepatic fatalities: a retrospective review","volume":"37","author":"Dreifuss","year":"1987","journal-title":"Neurology"},{"key":"2019041210494697800_b35-0710037","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.1840070130","article-title":"Reye\u2019s syndrome: current concepts","volume":"7","author":"Heubi","year":"1987","journal-title":"Hepatology"},{"key":"2019041210494697800_b36-0710037","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-0029-1240002","article-title":"Epidemiology of idiosyncratic drug-induced liver injury","volume":"29","author":"Bell","year":"2009","journal-title":"Semin Liver Dis"},{"key":"2019041210494697800_b37-0710037","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"2019041210494697800_b38-0710037","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(97)80492-8","article-title":"Genetic predisposition to drug-induced hepatotoxicity","volume":"26","author":"Larrey","year":"1997","journal-title":"J Hepatol"},{"key":"2019041210494697800_b39-0710037","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Pharmacogenomics\u2014drug disposition, drug targets, and side effects","volume":"348","author":"Evans","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041210494697800_b40-0710037","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4321\/S1130-01082011000900006","article-title":"Hepatotoxicity in 2011\u2014 advancing resolutely","volume":"103","author":"Lozano-Lanagran","year":"2011","journal-title":"Rev Esp Enferm Dig"},{"key":"2019041210494697800_b41-0710037","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1517\/14740338.3.4.329","article-title":"Causality assessment in drug-induced hepatotoxicity","volume":"3","author":"Andrade","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"2019041210494697800_b42-0710037","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/jhep.2001.25385","article-title":"Cigarette smoking and hepatic lesions in patients with chronic hepatitis C","volume":"34","author":"Pessione","year":"2001","journal-title":"Hepatology"},{"key":"2019041210494697800_b43-0710037","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2002-30103","article-title":"Hepatotoxicity of antimicrobial agents","volume":"22","author":"Brown","year":"2002","journal-title":"Semin Liver Dis"},{"key":"2019041210494697800_b44-0710037","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0002-9149(02)02355-X","article-title":"The liver and lovastatin","volume":"89","author":"Tolman","year":"2002","journal-title":"Am J Cardiol"},{"issue":"8A","key":"2019041210494697800_b45-0710037","doi-asserted-by":"crossref","first-page":"77C","DOI":"10.1016\/j.amjcard.2005.12.014","article-title":"An assessment of statin safety by hepatologists","volume":"97","author":"Cohen","year":"2006","journal-title":"Am J Cardiol"},{"key":"2019041210494697800_b46-0710037","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1345\/aph.1P099","article-title":"Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease","volume":"44","author":"Cone","year":"2010","journal-title":"Ann Pharmacother"},{"key":"2019041210494697800_b47-0710037","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1572-0241.1999.01119.x","article-title":"Acute hepatitis related to omeprazole","volume":"94","author":"Romero-Gomez","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"suppl 10, pt 2","key":"2019041210494697800_b48-0710037","doi-asserted-by":"crossref","first-page":"253S","DOI":"10.1592\/phco.21.16.253S.33993","article-title":"Fluoroquinolone adverse effects and drug interactions","volume":"21","author":"Fish","year":"2001","journal-title":"Pharmacotherapy"},{"key":"2019041210494697800_b49-0710037","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0168-8278(02)00268-4","article-title":"Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn\u2019s disease","volume":"37","author":"Bataille","year":"2002","journal-title":"J Hepatol"},{"key":"2019041210494697800_b50-0710037","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1525-1497.1999.10198.x","article-title":"Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database","volume":"14","author":"Petersen","year":"1999","journal-title":"J Gen Intern Med"},{"key":"2019041210494697800_b51-0710037","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jclinepi.2006.07.011","article-title":"Veteran\u2019s affairs hospital discharge databases coded serious bacterial infections accurately","volume":"60","author":"Schneeweiss","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"2019041210494697800_b52-0710037","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2036.2006.02985.x","article-title":"Validation of administrative data used for the diagnosis of upper gastrointestinal events following nonsteroidal anti-inflammatory drug prescription","volume":"24","author":"Abraham","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2019041210494697800_b53-0710037","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1472-6963-7-159","article-title":"Validation of ICD-9-CM\/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data","volume":"7","author":"Myers","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"2019041210494697800_b54-0710037","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1572-0241.2007.01456.x","article-title":"Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury","volume":"102","author":"Jinjuvadia","year":"2007","journal-title":"Am J Gastroenterol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/1\/37\/28371957\/ajhp0037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:41:38Z","timestamp":1555116098000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/1\/37\/5110881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp130165","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,1,1]]},"published":{"date-parts":[[2014,1,1]]}}}